Hypocitraturia is present when renal function is impaired in diverse nephropathies and is not related with serum bicarbonate levels

被引:1
作者
Borrego Utiel, Francisco Jose [1 ]
Herrera Contreras, Isidoro [2 ]
Merino Garcia, Enoc [1 ]
Moriana Dominguez, Clara [1 ]
Ocana Perez, Esther [2 ]
Garcia Cortes, Maria Jose [1 ]
机构
[1] Hosp Univ Jaen, Unidad Gest Clin UGC Nefrol, Jaen, Spain
[2] Hosp Univ Jaen, UGC Anal Clin, Jaen, Spain
关键词
Autosomal dominant polycystic kidney disease; Citrate; Uric acid; Chronic kidney disease; Glomerular disease; POLYCYSTIC KIDNEY-DISEASE; URIC-ACID; IGA NEPHROPATHY; PROGRESSION; CITRATE; NEPHROLITHIASIS; THERAPY; VOLUME;
D O I
10.1007/s11255-021-02992-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background In autosomal dominant polycystic kidney disease (ADPKD) it is frequently found a reduction in urinary citrate of unknown origin. It has been suggested that it could be a marker of acid retention in chronic kidney disease. Our aim was to compare urinary citrate in ADPKD with other nephropathies and to show its relation with serum bicarbonate. Methods We determined urinary citrate in patients with several nephropathies and varied renal function. We included 291 patients, 119 with glomerular diseases, 116 with ADPKD, 21 with other nephropathies, and 35 patients with normal renal function. Results Urinary citrate was higher in women and in patients with normal renal function. ADPKD patients showed similar values of urinary citrate to patients with glomerular diseases and with other nephropathies. We observed a progressive reduction in urinary citrate with renal impairment, in a comparable way among patients with ADPKD and glomerular diseases. We did not observe a relationship with serum bicarbonate. Serum uric acid levels were significantly higher in patients with glomerular diseases than in ADPKD patients, even after correction with the degree of renal function. Conclusions Hypocitraturia is not specific of ADPKD but it is also present in all tested nephropathies and is related with renal impairment and not with serum bicarbonate. It could be interesting to study urinary citrate as a marker of renal function and as a prognostic factor.
引用
收藏
页码:1261 / 1269
页数:9
相关论文
共 33 条
[1]   RENAL METABOLISM OF CITRATE [J].
BARUCH, SB ;
BURICH, RL ;
EUN, CK ;
KING, VF .
MEDICAL CLINICS OF NORTH AMERICA, 1975, 59 (03) :569-582
[2]   Urinary citrate as a marker of renal function in patients with autosomal dominant polycystic kidney disease [J].
Borrego Utiel, Francisco Jose ;
Herrera Contreras, Isidoro ;
Merino Garcia, Enoc ;
Camacho Reina, Maria Victoria ;
Moriana Dominguez, Clara ;
Ocana Perez, Esther .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (04) :873-881
[3]   Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis [J].
Bose, Bhadran ;
Badve, Sunil V. ;
Hiremath, Swapnil S. ;
Boudville, Neil ;
Brown, Fiona G. ;
Cass, Alan ;
de Zoysa, Janak R. ;
Fassett, Robert G. ;
Faull, Randall ;
Harris, David C. ;
Hawley, Carmel M. ;
Kanellis, John ;
Palmer, Suetonia C. ;
Perkovic, Vlado ;
Pascoe, Elaine M. ;
Rangan, Gopala K. ;
Walker, Robert J. ;
Walters, Giles ;
Johnson, David W. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (02) :406-413
[4]   The Clinical Significance of Uric Acid and Complement Activation in the Progression of IgA Nephropathy [J].
Caliskan, Yasar ;
Ozluk, Yasemin ;
Celik, Dilara ;
Oztop, Nida ;
Aksoy, Aysun ;
Ucar, Ayse Serra ;
Yazici, Halil ;
Kilicaslan, Isin ;
Sever, Mehmet Sukru .
KIDNEY & BLOOD PRESSURE RESEARCH, 2016, 41 (02) :148-157
[5]   Long-Term Treatment with Potassium Citrate and Renal Stones in Medullary Sponge Kidney [J].
Fabris, Antonia ;
Lupo, Antonio ;
Bernich, Patrizia ;
Abaterusso, Cataldo ;
Marchionna, Nicola ;
Nouvenne, Antonio ;
Gambaro, Giovanni .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (09) :1663-1668
[6]   Urine citrate excretion identifies changes in acid retention as eGFR declines in patients with chronic kidney disease [J].
Goraya, Nimrit ;
Simoni, Jan ;
Sager, Lauren N. ;
Mamun, Abdullah ;
Madias, Nicolaos E. ;
Wesson, Donald E. .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2019, 317 (02) :F502-F511
[7]   Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis [J].
Goraya, Nimrit ;
Simoni, Jan ;
Sager, Lauren N. ;
Madias, Nicolaos E. ;
Wesson, Donald E. .
KIDNEY INTERNATIONAL, 2019, 95 (05) :1190-1196
[8]   RENAL HANDLING OF CITRATE [J].
HAMM, LL .
KIDNEY INTERNATIONAL, 1990, 38 (04) :728-735
[9]   Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease [J].
Han, Miyeun ;
Park, Hayne Cho ;
Kim, Hyunsuk ;
Jo, Hyung Ah ;
Huh, Hyuk ;
Jang, Joon Young ;
Kang, Ah-Young ;
Kim, Seung Hyup ;
Cheong, Hae Il ;
Kang, Duk-Hee ;
Yang, Jaeseok ;
Oh, Kook-Hwan ;
Hwang, Young-Hwan ;
Ahn, Curie .
BMC NEPHROLOGY, 2014, 15
[10]   Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease [J].
Helal, Imed ;
McFann, Kim ;
Reed, Berenice ;
Yan, Xiang-Dong ;
Schrier, Robert W. ;
Fick-Brosnahan, Godela M. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (02) :380-385